Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other financing activities (2017 - 2020)

Historic Other financing activities for Rocket Pharmaceuticals (RCKT) over the last 2 years, with Q2 2020 value amounting to $139000.0.

  • Rocket Pharmaceuticals' Other financing activities changed N/A to $139000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $139000.0, marking a year-over-year increase of 4183.67%. This contributed to the annual value of $237000.0 for FY2020, which is N/A changed from last year.
  • As of Q2 2020, Rocket Pharmaceuticals' Other financing activities stood at $139000.0.
  • Over the past 5 years, Rocket Pharmaceuticals' Other financing activities peaked at $139000.0 during Q2 2020, and registered a low of -$3.2 million during Q4 2017.